Schonfeld Strategic Advisors’s Carisma Therapeutics CARM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-630
| Closed | -$10K | – | 2001 |
|
|
2021
Q3 | $10K | Sell |
630
-190,780
| -100% | -$3.03M | ﹤0.01% | 1947 |
|
|
2021
Q2 | $17.7M | Buy |
191,410
+23,705
| +14% | +$2.19M | 0.19% | 142 |
|
|
2021
Q1 | $8.72M | Buy |
167,705
+150,246
| +861% | +$7.81M | 0.11% | 236 |
|
|
2020
Q4 | $471K | Sell |
17,459
-2,931
| -14% | -$79.1K | 0.01% | 1015 |
|
|
2020
Q3 | $571K | Buy |
+20,390
| New | +$571K | 0.01% | 837 |
|
|
2019
Q3 | – | Sell |
-62,785
| Closed | -$1.88M | – | 1013 |
|
|
2019
Q2 | $1.88M | Buy |
+62,785
| New | +$1.88M | 0.07% | 303 |
|
|
2019
Q1 | – | Sell |
-47,518
| Closed | -$1.35M | – | 1038 |
|
|
2018
Q4 | $1.35M | Buy |
47,518
+8,613
| +22% | +$245K | 0.05% | 403 |
|
|
2018
Q3 | $1.67M | Buy |
+38,905
| New | +$1.67M | 0.07% | 323 |
|